1. Factors to Consider When Making Benefit–risk Determinations in Medical Device Premarket Approval and De Novo Classifications;FDA,2016
2. Incorporating patient-preference evidence into regulatory decision making;Ho;Surg. Endosc.,2014
3. Patient Preference Information — Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling;FDA,2016
4. Is the FDA Too Conservative or Too Aggressive? A Bayesian Decision Analysis of Clinical Trial Design;Isakov,2015
5. Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology;Montazerhodjat;JAMA Oncol.,2017